The LY86-AS1 gene, also known as LY86 antisense RNA 1, is a long non-coding RNA (lncRNA) located on chromosome 1 in humans. Although there may be limited information on its specific functions compared to protein-coding genes, several interesting aspects can be observed regarding its associations and roles.

### 1. Associated Genes
Although specific genes directly associated with LY86-AS1 may not be extensively documented, LncRNAs often have regulatory effects on neighboring or functionally linked genes. LY86-AS1 is located near the LY86 gene (lymphocyte antigen 86), which is related to the immune response. There may also be indirect associations with other genes involved in inflammation and immune modulation given the function of LY86.

### 2. Aging and Age-Related Diseases
While there may not be a direct correlation between LY86-AS1 and aging-related pathways explicitly documented, lncRNAs have been increasingly recognized for their regulatory roles in cellular senescence and age-associated diseases, like cancer and cardiovascular diseases. The immune modulation function of the LY86 gene might suggest relevance for inflammatory responses often linked to aging and age-related pathologies. Further studies may be necessary to explicitly establish LY86-AS1’s role in these processes.

### 3. Drug Interactions
Specific drugs or drug classes that directly interact with LY86-AS1 have not been significantly documented in the current literature. However, given its role in immune regulation, there may be potential indirect interactions through pathways modulated by immune-modulating therapies or anti-inflammatory drugs.

### 4. Pathways and Biological Processes
LY86-AS1 may be involved in several biological processes, primarily through its regulatory function associated with the LY86 gene and potentially affecting pathways related to:
- **Immune Response:** As LY86 is associated with immune cell signaling, LY86-AS1 may also play a role in modulating immune responses.
- **Regulation of Gene Expression:** Long non-coding RNAs commonly participate in transcriptional regulation, chromatin remodeling, and modulation of other genetic pathways.

In summary, while direct information on LY86-AS1 is limited, it is implicated in immune-related functions and may have associations with genes involved in inflammation. Research surrounding lncRNAs continues to evolve, and LY86-AS1 could yield further discoveries, especially concerning age-related diseases and potential therapeutic targets in the future. For the latest specific drug interactions or biological implications, continuous literature checks and functional studies are recommended.